To determine whether cyclopamine has a similar effect on ER-α production, MCF-7 human breast cancer cells were treated with a range of concentrations of cyclopamine and the level of total ER-α protein was monitored by western blot analysis of total cell extracts. Here, ESR1 is linked to breast carcinoma.